Current Opinion in Rheumatology

• 

  Publication Venue For

  • Stem cell-based therapies for osteoarthritis: challenges and opportunities..  25:119-126. 2013
  • Pharmacogenomics in pediatric rheumatology.  24:541-547. 2012
  • Current Opinion in Rheumatology: Editorial introductions.  22. 2010
  • Editorial introductions.  21. 2009
  • Refractory gout: what is it and what to do about it?.  20:198-202. 2008
  • Pathogenesis of myositis in children..  19:487-491. 2007
  • Type II collagen markers in osteoarthritis: what do they indicate?.  19:444-450. 2007
  • Use of tumor necrosis factor inhibitors in uveitis..  19:482-486. 2007
  • Early rheumatoid arthritis..  19:278-283. 2007
  • Latest developments in the assessment and management of chronic musculoskeletal pain syndromes in children..  18:496-502. 2006
  • Biomarkers in osteoarthritis..  17:641-646. 2005
  • Infectious complications of treatment with biologic agents..  16:393-398. 2004
  • Osteoporosis considerations in the frail elderly..  15:481-486. 2003
  • Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseases..  14:204-211. 2002
  • Juvenile idiopathic arthritis..  13:392-398. 2001
  • Myositis in children..  13:428-433. 2001
  • Anti-DNA and autoantibodies..  12:364-368. 2000
  • Immune-mediated inner ear disease..  12:32-40. 2000
  • Cogan's syndrome..  11:47-52. 1999
  • Changing concepts in pathophysiology of the vasculitides..  6:3-10. 1994
  • Autoantibodies and their significance..  5:549-556. 1993
  • New developments in Sjögren's syndrome..  5:604-612. 1993
  • Miscellaneous vasculitic syndromes including Behçet's disease and central nervous system vasculitis..  5:51-56. 1993
  • Autoantibodies and their idiotypes..  4:635-643. 1992
  • Autoantibodies and their idiotypes..  3:731-737. 1991